Canavan Disease: Analysis of the Nature of the Metabolic Lesions Responsible for Development of the Observed Clinical Symptoms

Journal of Molecular Neuroscience

Volumn 9, Issue 2, 1997, Pages 109-125

  Baslow, Morris H ^a   Resnik, Tracy R ^a  

^a NATHAN S KLINE INSTITUTE FOR PSYCHIATRIC RESEARCH   (United States)

Author keywords

Canavan disease; Hypoaspartia; N acetylaspartate; N acetylaspartic acidemia; N acetylaspartic aciduria; N acetylhistidine

Indexed keywords

VERTEBRATA;

AMIDASE; ASPARTIC ACID; ASPARTOACYLASE; DRUG DERIVATIVE; HISTIDINE; N ACETYLASPARTIC ACID; N ACETYLHISTIDINE; N-ACETYLASPARTATE; N-ACETYLHISTIDINE;

ANIMAL; CANAVAN DISEASE; CENTRAL NERVOUS SYSTEM; FEMALE; FETUS DISEASE; HUMAN; METABOLISM; PREGNANCY; REVIEW;

AMIDOHYDROLASES; ANIMALS; ASPARTIC ACID; CANAVAN DISEASE; CENTRAL NERVOUS SYSTEM; FEMALE; FETAL DISEASES; HISTIDINE; HUMANS; PREGNANCY;

EID: 0031243417     PISSN: 08958696     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02736855     Document Type: Article

References (55)

1. Adachi M. and Volk B. W. (1968) Protracted form of spongy degeneration of the central nervous system (van Bogaert and Bertrand type). Neurology 18, 1084-1092.
2. Afanas'ev I., Suslova T. B., Cheremisina Z. P., Abramova N. E., and Korkina L. G. (1995) Study of antioxidant properties of metal aspartates. Analyst 120, 859-862.
3. Baslow M. H. (1997) A review of phylogenetic and metabolic relationships between the acylamino acids, N-acetyl-L-aspartic acid and N-acetyl-L-histidine in the vertebrate nervous system. J. Neurochem. 68, 1335-1344.
4. Baslow M. H. and Lenney J. F. (1967) a-N-Acetylhistidine amido-hydrolase activity from tuna fish brain: inhibition by phenothiazines. Seventh Int. Cong. Biochem. 5, 1014.
5. Baslow M. H. and Nigrelli R. F. (1961) Muscle acetylcholinesterase as an index of general activity in fishes. Copeia 1, 8-11.
6. Baslow M. H. and Nigrelli R. F. (1964) The effect of thermal acclimation on brain cholinesterase activity of the killifish, Fundulus heteroclitus. Zoologica 49(1), 41-51.
7. Baslow M. H. and Yamada S. (1997a) Identification of N-acetylaspartate in the lens of the vertebrate eye: a new model for the investigation of the function of N-acetylated amino acids in vertebrates. Exp. Eye Res. 64(2), 283-286.
8. Baslow M. H. and Yamada S. (1997b) Distribution of N-acetyl-L-histidine and N-acetyl-L-aspartate in the vertebrate eye. J. Neurochem. 69 (Suppl.), 5175D.
9. Bennett M. J., Gibson K. M., Sherwood W. G., Divry P., Rolland M. O., Elpeleg O. N., Rinaldo P., and Jakobs C. (1993) Reliable prenatal diagnosis of Canavan disease (aspartoacylase deficiency): comparison and enzymatic and metabolite analysis. J. Inher. Met. Dis. 16, 831-836.
10. Berlinguet L. and Laliberte M. (1966) Metabolism of N-acetyl-L-aspartic acid in mice. Can. J. Biochem. 44, 783-789.
11. Birken D. L. and Oldendorf W. H. (1989) N-Acetyl-L-aspartic acid: a literature review of a compound prominent in H-NMR spectroscopic studies of brain. Neurosci. Biobehav. Rev. 13, 23-31.
12. Boehme D. H. and Marks N. (1981) Protracted form of Canavan's disease: casehistory and protein kinase activity of membrane fractions. Acta Neuropathol. 55, 221-225.
13. Bremer H. J., Duran M., Kamerling J. P., Przyrembel H., and Wadman S. K. (1981) Disturbances of amino acid metabolism: clinical chemistry and diagnosis. Urban and Schwarzenberg, Baltimore, MD, p. 536.
14. Buniatian H. C. H., Hovhannissian V. S., and Aprikian G. V. (1965) The participation of N-acetyl-L-aspartic acid in brain metabolism. J. Neurochem. 12, 695-703.
15. Burns S. P., Charmers R. A., West R. J., and Iles R. A. (1992) Measurement of human brain aspartate N-acetyl transferase flux in vivo. Biochem. Soc. Trans. 20, 107S.
16. Canavan M. M. (1931) Schilders encephalitis periaxialis diffusa. Report of a case in a child aged sixteen and one-half months. Arch. Neurol. Psychiat. 25, 299-308.
17. Christensen H. N. (1990) Role of amino acid transport and countertransport in nutrition and metabolism. Physiol. Rev. 70, 43-77.
18. D'Adamo A. F. Jr., Smith J. C., and Woiler C. (1973) The occurrence of N-acetylaspartate amidohydrolase (aminoacylase II) in the developing rat. J. Neurochem. 20, 1275-1278.
19. During M. (1996) Gene therapy in New Zealand (letter). Science 272, 467.
20. Elpeleg O. N., Shaag A., Anikster Y., and Jakobs C. (1994) Prenatal detection of Canavan disease (aspartoacylase deficiency) by DNA analysis. J. Inher. Met. Dis. 17, 664-666.
21. Ferrari M. D., Odink J., Bos K. D., Malessy M. J. A., and Bruyn G. W. (1990) Neuroexcitatory plasma amino acids are elevated in migraine. Neurology 40, 1582-1586.
22. Ford F. R. (1960) Diseases of the Nervous System in Infancy, Childhood and Adolescence. Charles C. Thomas, Pub., Springfield, IL, p. 1548.
23. Goldstein F. B. (1976) Amidohydrolases of brain; enzymatic hydrolysis of N-acetyl-L-aspartate and other N-acyl-L-amino acids. J. Neurochem. 26, 45-49.
24. Kaul R., Casanova J., Johnson A. B., Tang P., and Matalon R. (1991) Purification, characterization, and localization of aspartoacylase from bovine brain. J. Neurochem. 56, 129-135.
25. Kaul R., Gao G. P., Balamurugan K., and Matalon R. (1993) Cloning of the human aspartoacylase cDN A and a common missense mutation in Canavan disease. Nature Gen. 5, 118-123.
26. Kaul R., Gao G. P., Aloya M., Balamurugan K., Petrosky A., Michals K., and Matalon R. (1994a) Canavan disease: mutations among Jewish and non-Jewish patients. Am. J. Hum. Gen. 55, 34-41.
27. Kaul R., Balamurugan K., Gao G. P., and Matalon R. (1994b) Canavan disease: genomic organization and localization of human ASPA to 17p13-ter and conservation of the ASPA gene during evolution. Genomics 21, 364-370.
28. Kaul R., Gao G. P., Matalon R., Aloya M., Su Q., Jin M., Johnson A. B., Schutgens R. B., and Clarke J. T. (1996) Identification and expression of eight novel mutations among non-Jewish patients with Canavan disease. Am. J. Hum. Gen. 59, 95-102.
29. Kelley R. I. (1993) Prenatal detection of Canavan disease by measurement of N-acetyl-L-aspartate in amniotic fluid. J. Inher. Metab. Dis. 16, 918,919.
30. Kish S. J., Robitaille Y., el-Awar M., Gilbert J., Deck J., Chang L. J., and Schut L. (1991) Brain amino acid reductions in one family with chromosome 6p-linked dominantly inherited olivopontocerebellar atrophy. Ann. Neurol. 30, 780-784.
31. Kvittingen E. A., Guldal G., Bursting S., Skalpe I. O., Stokke O., and Jellum E. (1986) N-acetylaspartic aciduria in a child with a progressive cerebral atrophy. Clin. Chim. Acta 158, 217-227.
32. Levine R. J. (1996) Canavan gene therapy protocol (letter) Science 272, 1085.
33. Matalon R., Michals K., Sebasta D., Deanching M., Gashkoff P., and Casanova J. (1988) Aspartoacylase deficiency and N-acetylaspartic aciduria in patients with Canavan disease. Am. J. Med. Genet. 29, 463-471.
34. Matalon R., Kaul R., Casanova J., Michals K., Johnson A., Rapin I., Gashkoff P., and Deanching M. (1989) Aspartoacylase deficiency: the enzyme defect in Canavan disease. J. Inher. Metab. Dis. 12, 329-331.
35. Matalon R., Kaul R., and Michals K. (1993) Canavan disease: biochemical and molecular studies. J. Inher. Met. Dis. 16, 744-752.
36. Matalon R., Michals K., and Kaul R. (1995) Canavan disease: from spongy degeneration to molecular analysis. J. Pediatr. 127, 511-517.
37. Oldendorf W. H. (1971) Brain uptake of radiolabeled amino acids, amines, and hexoses after arterial injection. Am. J. Physiol. 221, 1629-1639.
38. Pevzner L. Z. (1979) Functional Biochemistry of the Neuroglia (Tiplady B., ed.), Plenum, New York, p. 306.
39. Reddy D. V. N. (1967) Distribution of free amino acids and related compounds in ocular fluids, lens and plasma of various mammalian species. Invest. Opthalmol. 6, 478-483.
40. Reilmann R., Rolf L. H., and Lange H. W. (1994) Huntington's disease: the neuroexcitatoxin aspartate is increased in platelets and decreased in plasma. J. Neurol. Sci. 127, 48-53.
41. Riikonen R. S., Kero P. O., and Simell O. G. (1992) Excitatory amino acids in cerebrospinal fluid in neonatal asphyxia. Pediatr. Neurol. 8, 37-40.
42. Sager T. N., Fink-Jensen A., and Hansen A. J. (1997) Transient elevation of interstitial N-acetylaspartate in reversible global brain ischemia. J. Neurochem. 68, 675-682.
43. Sandberg M., Butcher S. P., and Hagberg H. (1986) Extracellular overflow of neuroactive amino acids during severe insulin-induced hypoglycemia: in vivo dialysis of the rat hippocampus. J. Neurochem. 47, 178-184.
44. Scriver C. R. and Rosenberg L. E. (1973) Amino acid metabolism and its disorders, in Major Problems in Clinical Pediatrics, vol. X (Schaffer A. L., ed.), Saunders, Philadelphia, PA, p. 491.
45. Shaag A., Anikster Y., Christensen E., Glustein J. Z., Fois A., Michelakakis H., Nigro F., Pronicka E., Ribes A., Zabot M. T., et al. (1995) The molecular basis of Canavan (aspartoacylase deficiency) disease in European non-Jewish patients. Am. J. Hum. Gen. 57, 572-580.
46. Swahn C. G. (1990) Determination of N-acetylaspartic acid in human cerebrospinal fluid by gas chromatography-mass spectrometry. J. Neurochem. 54, 1584-1588.
47. Tallan H. H. (1957) Studies on the distribution of N-acetyl-L-aspartic acid in brain. J. Biol. Chem. 224, 41-45.
48. Tallan H. H., Moore S., and Stein W. H. (1954) Studies on the free amino acids and related compounds in the tissues of the cat. J. Biol. Chem. 211, 927-939.
49. Truckenmiller M. E., Namboodiri M. A. A., Browstein M. J., and Neale J. H. (1985) N-Acetylation of L-aspartate in the nervous system: differential distribution of a specific enzyme. J. Neurochem. 45, 1658-1662.
50. Urenjak J., Williams S. R., Gadian D. G., and Noble M. (1992) Specific expression of N-acetylaspartate in neurons, oligodendrocyte-type-2 astrocyte progenitors, and immature oligodendrocytes in vitro. J. Neurochem. 59, 55-61.
51. Yamada S., Tanaka Y., Sameshima M., and Furuichi M. (1992) Occurrence of N-acetylhistidine in the muscle and deacetylation by several tissues of Nile tilapia (Oreochromis niloticus). Comp. Biochem. Physiol. [B] 103, 579-583.
52. Yamada S., Tanaka Y., Sameshima M., and Furuichi M. (1993) Properties of N-acetylhistidine deacetylase in brain of trout Oncorhynchus mykiss. Comp. Biochem. Physiol. [B] 106, 309-315.
53. Yamada S., Tanaka Y., Sameshima M., and Furiuchi M. (1994) Effects of starvation and feeding on tissue N-acetylhistidine levels in Nile tilapia Oreochromis niloticus. Comp. Biochem. Physiol. [A] 109, 277-283.
54. Yamada S., Tanaka Y., and Furuichi M. (1995) Partial purification and characterization of histidine acetyltransferase in brain of Nile tilapia (Oreochromis niloticus). Biochim. Biophys. Acta 1245, 239-247.
55. Winick M. (1976) Malnutrition and Brain Development. Oxford University Press, New York, p. 169.